Article (Périodiques scientifiques)
Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia.
Shaabanpouraghamaleki, Fateme; Mollashahi, Behrouz; Nosrati, Mokhtar et al.
2019In Cureus, 11 (2), p. 4004
Editorial reviewed
 

Documents


Texte intégral
1612428403-1612428398-20210204-18268-103veor.pdf
Postprint Auteur (680.92 kB)
Télécharger

Tous les documents dans ORBi sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
artificial neural network; biomarkers; chronic lymphocytic leukemia; diagnosis
Résumé :
[en] Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. Materials & methods The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. Results The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. Conclusions With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome.
Disciplines :
Génétique & processus génétiques
Auteur, co-auteur :
Shaabanpouraghamaleki, Fateme  ;  Université de Liège - ULiège > Faculté des Sciences > Form. doct. sc. (bioch., biol. mol. cel., bioinf. - paysage) ; Genetics, Shahid Beheshti University of Medical Sciences, Tehran, IRN
Mollashahi, Behrouz;  Genetics, Shahid Beheshti University of Medical Sciences, Tehran, IRN
Nosrati, Mokhtar;  Genetics, University of Isfahan, Isfahan, IRN
Moradi, Afshin;  Pathology, Shahid Beheshti University of Medical Science, Tehran, IRN
Sheikhpour, Mojgan;  Genetics, Pasteur Institute of Iran, Tehran, IRN
Movafagh, Abolfazl;  Genetics, Shahid Beheshti University of Medical Sciences, Tehran, IRN
Langue du document :
Anglais
Titre :
Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia.
Date de publication/diffusion :
04 février 2019
Titre du périodique :
Cureus
eISSN :
2168-8184
Maison d'édition :
Springer Science and Business Media LLC, Etats-Unis
Volume/Tome :
11
Fascicule/Saison :
2
Pagination :
e4004
Peer reviewed :
Editorial reviewed
Disponible sur ORBi :
depuis le 29 avril 2024

Statistiques


Nombre de vues
28 (dont 2 ULiège)
Nombre de téléchargements
28 (dont 1 ULiège)

OpenCitations
 
6
citations OpenAlex
 
22

Bibliographie


Publications similaires



Contacter ORBi